相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Empagliflozin in Patients with Chronic Kidney Disease
William G. Herrington et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo
Mark A. Hlatky et al.
JAMA CARDIOLOGY (2023)
American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity
Karl Nadolsky et al.
ENDOCRINE PRACTICE (2023)
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Rajiv Agarwal et al.
EUROPEAN HEART JOURNAL (2022)
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2022)
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
Aruna Das Pradhan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update
Lawrence Blonde et al.
ENDOCRINE PRACTICE (2022)
What's preventing us from curbing the obesity crisis?
[Anonymous]
LANCET DIABETES & ENDOCRINOLOGY (2022)
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2022)
Tirzepatide Once Weekly for the Treatment of Obesity
Ania M. Jastreboff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis (vol 43, pg 474, 2022)
Rajiv Agarwal et al.
EUROPEAN HEART JOURNAL (2022)
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function Insights From EMPEROR-Reduced
Faiez Zannad et al.
CIRCULATION (2021)
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis
Darren K. McGuire et al.
JAMA CARDIOLOGY (2021)
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT
Muhammad Abdul-Ghani et al.
DIABETES CARE (2021)
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes
Justin M. Gregory et al.
DIABETES CARE (2021)
Predictive value of abnormal ankle-brachial index in patients with diabetes: A meta-analysis
Fengze Nie et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial
Thomas A. Wadden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John P. H. Wilding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
Hiddo J. L. Heerspink et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Naveed Sattar et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial
Domenica Rubino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Comparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: two randomized crossover non-inferiority studies
Mark P. Christiansen et al.
BMJ OPEN DIABETES RESEARCH & CARE (2021)
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
Camilla Ditlev Lindhardt Johannesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Usefulness of Glucagon-Like Peptide-1 Receptor Agonists to Reduce Adverse Cardiovascular Disease Events in Patients with Type 2 Diabetes Mellitus
Simran Grewal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis
Rhea E. Powell et al.
DIABETES OBESITY & METABOLISM (2021)
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus
George Grunberger et al.
ENDOCRINE PRACTICE (2021)
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin A Randomized Clinical Trial
Thomas Martens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes
Andrew J. Karter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis
Wen-Hsuan Tsai et al.
SCIENTIFIC REPORTS (2021)
Stroke Risk Factors in United States: An Analysis of the 2013-2018 National Health and Nutrition Examination Survey
Zhouming Ren et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials
Edoardo Mannucci et al.
ENDOCRINE (2021)
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2018
Peng-Jun Lu et al.
MMWR SURVEILLANCE SUMMARIES (2021)
Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials
Safi U. Khan et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta-analysis and cost-effectiveness analysis
Peng Men et al.
DIABETES OBESITY & METABOLISM (2020)
Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
Nahid Hashemi Madani et al.
BMC CARDIOVASCULAR DISORDERS (2020)
Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney Disease
Johannes F. E. Mann et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2020 EXECUTIVE SUMMARY
Alan J. Garber et al.
ENDOCRINE PRACTICE (2020)
Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study
Jing-Lu Jin et al.
CARDIOVASCULAR DIABETOLOGY (2020)
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Sandeep R. Das et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists
C. Berraa et al.
PHARMACOLOGICAL RESEARCH (2020)
Coronary Artery Calcification Under Statin Therapy and Its Effect on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Runmin Lai et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE ALGORITHM-2020 EXECUTIVE SUMMARY
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2020)
Two-year-supervised resistance training prevented diabetes incidence in people with prediabetes: A randomised control trial
Xia Dai et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2019 EXECUTIVE SUMMARY
Alan J. Garber et al.
ENDOCRINE PRACTICE (2019)
Pioglitazone Therapy in Patients With Stroke and Prediabetes A Post Hoc Analysis of the IRIS Randomized Clinical Trial
J. David Spence et al.
JAMA NEUROLOGY (2019)
Association of Nonfasting vs Fasting Lipid Levels With Risk of Major Coronary Events in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm
Samia Mora et al.
JAMA INTERNAL MEDICINE (2019)
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
David R. Matthews et al.
LANCET (2019)
Benefits and harms of intensive glycemic control in patients with type 2 diabetes
Rene Rodriguez-Gutierrez et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Connie B. Newman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
Allan D. Sniderman et al.
JAMA CARDIOLOGY (2019)
Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study
Rianneke de Ritter et al.
BMJ OPEN DIABETES RESEARCH & CARE (2019)
The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes
Robert A. Vigersky et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss
Frank L. Greenway et al.
OBESITY (2019)
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants
Nelson Wang et al.
Lancet Diabetes & Endocrinology (2019)
Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines
Vasanth Sathiyakumar et al.
CIRCULATION (2018)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2018 EXECUTIVE SUMMARY
Alan J. Garber et al.
ENDOCRINE PRACTICE (2018)
Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited
Tracy Ann Williams et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Impacts of Prediabetes Mellitus Alone or Plus Hypertension on the Coronary Severity and Cardiovascular Outcomes
Hui-Hui Liu et al.
HYPERTENSION (2018)
Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review
Gael Dos Santos et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet: Results of the PREDIMED-Reus nutrition intervention randomized trial (vol 34, pg 14, 2011)
Jordi Salas-Salvado et al.
DIABETES CARE (2018)
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
Richard M. Bergenstal et al.
DIABETES CARE (2018)
Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Results From the LEADER Trial
Johannes F. E. Mann et al.
CIRCULATION (2018)
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Robert M. Carey et al.
HYPERTENSION (2018)
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial
Valeria Saglimbene et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog
Ulrike Hoevelmann et al.
DIABETES CARE (2018)
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
Kamlesh Khunti et al.
DIABETES OBESITY & METABOLISM (2018)
Dietary sugars versus glucose tablets for first-aid treatment of symptomatic hypoglycaemia in awake patients with diabetes: a systematic review and meta-analysis
Jestin N. Carlson et al.
EMERGENCY MEDICINE JOURNAL (2017)
Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis
Meng Lee et al.
STROKE (2017)
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
Thomas Haak et al.
DIABETES THERAPY (2017)
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
Thomas Haak et al.
DIABETES THERAPY (2017)
Updated risk factors should be used to predict development of diabetes
Mary Angelyn Bethel et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Carel W. le Roux et al.
LANCET (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
Rury R. Holman et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
Julian P. Halcox et al.
BMC CARDIOVASCULAR DISORDERS (2017)
A Mediterranean diet lowers blood pressure and improves endothelial function: results from the MedLey randomized intervention trial
Courtney R. Davis et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2017)
Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus
Lawrence H. Young et al.
CIRCULATION (2017)
ADIPOSITY-BASED CHRONIC DISEASE AS A NEW DIAGNOSTIC TERM: THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT
Jeffrey I. Mechanick et al.
ENDOCRINE PRACTICE (2017)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE
Paul S. Jellinger et al.
ENDOCRINE PRACTICE (2017)
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study
Michael R. Rickels et al.
DIABETES CARE (2016)
Warranty Period of Zero Coronary Artery Calcium Score for Predicting All-Cause Mortality According to Cardiac Risk Burden in Asymptomatic Korean Adults
Ji Hyun Lee et al.
CIRCULATION JOURNAL (2016)
Age, Gender, and Race-Based Coronary Artery Calcium Score Percentiles in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
Alexandre C. Pereira et al.
CLINICAL CARDIOLOGY (2016)
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
Jennifer L. Sherr et al.
DIABETES CARE (2016)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2016 EXECUTIVE SUMMARY
Alan J. Garber et al.
ENDOCRINE PRACTICE (2016)
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Nicholas J. Viney et al.
LANCET (2016)
Bias in the measure of the effectiveness of seasonal influenza vaccination among diabetics
Ludouic Casanova et al.
PRIMARY CARE DIABETES (2016)
BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin
Ariel Zisman et al.
BMJ OPEN DIABETES RESEARCH & CARE (2016)
Traditional cardiovascular disease risk factors associated with one-year all-cause mortality among those with coronary artery calcium scores ≥400
Mahmoud Al Rifai et al.
ATHEROSCLEROSIS (2015)
Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)
J. Vora et al.
DIABETES OBESITY & METABOLISM (2015)
Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
Feng Sun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2015 EXECUTIVE SUMMARY
Alan J. Garber et al.
ENDOCRINE PRACTICE (2015)
Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011
Emily B. Schroeder et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
Faiez Zannad et al.
LANCET (2015)
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
Suetonia C. Palmer et al.
LANCET (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The WHO-5 Well-Being Index: A Systematic Review of the Literature
Christian Winther Topp et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)
The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity
Jaime Ponce et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2015)
AACE Comprehensive Diabetes Management Algorithm 2013
Alan Garber et al.
Endocrine Practice (2015)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (vol 63, pg 2889, 2014)
N. J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Prevention of Diabetes With Mediterranean Diets A Subgroup Analysis of a Randomized Trial
Jordi Salas-Salvado et al.
ANNALS OF INTERNAL MEDICINE (2014)
US Physicians' Perspective of Adult Vaccine Delivery
Laura P. Hurley et al.
ANNALS OF INTERNAL MEDICINE (2014)
Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
W. Timothy Garvey et al.
DIABETES CARE (2014)
Efficacy of interventions that include diet, aerobic and resistance training components for type 2 diabetes prevention: a systematic review with meta-analysis
Elroy J. Aguiar et al.
INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY (2014)
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Robert H. Eckel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis
William L. Baker et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3-and 6-month study
George Marinos et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2014)
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome
Roberto R. Giraldez et al.
AMERICAN HEART JOURNAL (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis
Caroline Kaercher Kramer et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
Meng Lee et al.
ATHEROSCLEROSIS (2011)
Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study
Juana A. Flores-Le Roux et al.
CARDIOVASCULAR DIABETOLOGY (2011)
A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
Allan D. Sniderman et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
Rena R. Wing et al.
DIABETES CARE (2011)
Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study
D. R. Owens et al.
DIABETES OBESITY & METABOLISM (2011)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
Eric Bruckert et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
Ralph A. DeFronzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Exercise and Type 2 Diabetes The American College of Sports Medicine and the American Diabetes Association joint position statement executive summary
Sheri R. Colberg et al.
DIABETES CARE (2010)
Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement
S. R. Colberg et al.
DIABETES CARE (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Faramarz Ismail-Beigi et al.
LANCET (2010)
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Russell Scott et al.
DIABETES CARE (2009)
STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL
Helena W. Rodbard et al.
ENDOCRINE PRACTICE (2009)
Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988–2004
Dong-Churl Suh et al.
JOURNAL OF HYPERTENSION (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Barriers to adult immunization
David R. Johnson et al.
AMERICAN JOURNAL OF MEDICINE (2008)
STOP questionnaire - A tool to screen patients for obstructive sleep apnea
Frances Chung et al.
ANESTHESIOLOGY (2008)
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction The Reynolds Risk Score for Men
Paul M. Ridker et al.
CIRCULATION (2008)
Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
M. R. Lankisch et al.
DIABETES OBESITY & METABOLISM (2008)
Lipoprotein management in patients with cardiometabolic risk - Consensus conference report from the American diabetes association and the American college of cardiology foundation
John D. Brunzell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Initiate insulin by aggressive titration and education (INITIATE) - A randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups
Hannele Yki-Jarvinen et al.
DIABETES CARE (2007)
BioEnterics Intragastric Balloon: The Italian experience with 2,515 patients
A Genco et al.
OBESITY SURGERY (2005)
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic - A report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
M Rahman et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Physical activity in the prevention of type 2 diabetes - The Finnish Diabetes Prevention Study
DE Laaksonen et al.
DIABETES (2005)
Association of hemoglobin A1c with cardiovascular disease and mortality in adults:: The European prospective investigation into cancer in Norfolk
KT Khaw et al.
ANNALS OF INTERNAL MEDICINE (2004)
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial
JL Chiasson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Diabetic dyslipidaemia: from basic research to clinical practice
MR Taskinen
DIABETOLOGIA (2003)
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk
AD Sniderman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Influence of weight reduction on blood pressure - A meta-analysis of randomized controlled trials
JE Neter et al.
HYPERTENSION (2003)
The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
MC Riddle et al.
DIABETES CARE (2003)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
SM Grundy et al.
CIRCULATION (2002)
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
HM Lakka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study
DE Laaksonen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:: a prospective study
A Norhammar et al.
LANCET (2002)
Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
JL Chiasson et al.
LANCET (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The PHQ-9 - Validity of a brief depression severity measure
K Kroenke et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2001)
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study
F de Vegt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
β-Adrenergic receptor blockers and weight gain -: A systematic analysis
AM Sharma et al.
HYPERTENSION (2001)
Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet.
FM Sacks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
AI Adler et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Use of influenza and pneumococcal vaccines in people with diabetes
SA Smith et al.
DIABETES CARE (2000)